Enzon Inc. sales and marketing update

Enzon Inc. (ENZN) Rhone-Poulenc Rorer, ENZN's U.S. licensee for Oncaspar (pegaspargase), began U.S. sales of the drug to treat acute lymphoblastic leukemia (ALL). Rhone-Poulenc has priced the drug at...